EX-99.6

Please wait

F-cap 1

ANNUAL ACCOUNTS AND OTHER DOCUMENTS TO BE FILED IN

ACCORDANCE WITH THE BELGIAN COMPANIES AND ASSOCIATIONS

CODE

IDENTIFICATION DETAILS (at the filing date)

NAME: Galapagos


Legal form ¹: Public limited company

Address: Generaal De Wittelaan

Postal code: 2800	Town: Mechelen		N°. L11 , box A3

Country: Belgium

Register of legal persons - commercial court: Antwerp, division Mechelen

Website ²:

E-mail address²:

		Company registration number	0466.460.429

DATE 03-05-2024 of filing the most recent document mentioning the date of publication of the deed of incorporation and of the deed of amendment of the articles of association.

This filing concerns³:

☒ the ANNUAL ACCOUNTS in EURO⁴ approved by the general meeting of 28-04-2026

☒ the OTHER DOCUMENTS

regarding

the financial year covering the period from 01-01-2025 to 31-12-2025

the preceding period of the annual accounts from 01-01-2024 to 31-12-2024

The amounts for the preceding period are / ~~are not~~ ⁵ identical to the ones previously published.

Total number of pages filed: 61 Numbers of the sections of the standard model form not filed because they serve no useful purpose: 6.1, 6.2.1, 6.2.4, 6.3.5, 6.17, 6.18.2, 6.20, 7, 9, 11, 12, 13, 14, 15

Signature

(name and position)

Jérôme Contamine

Chairman of the board of directors

Signature

(name and position)

Henry Gosebruch

Director

¹	Where appropriate, “in liquidation” is stated after the legal form.

²	Optional mention.

³	Tick the appropriate box(es).

⁴	If necessary, change to currency in which the amounts are expressed.

⁵	Strike out what does not apply.

1/61


N°.		0466.460.429				F-cap 2.1

LIST OF DIRECTORS, BUSINESS MANAGERS AND AUDITORS AND

DECLARATION REGARDING A COMPLIMENTARY REVIEW OR

CORRECTION ASSIGNMENT

LIST OF DIRECTORS, BUSINESS MANAGERS AND AUDITORS

COMPLETE LIST with surname, first names, profession, place of residence (address, number, postal code and town) and position within the company

Higgins Linda

Generaal De Wittelaan L11, box A3, 2800 Mechelen, Belgium

Mandate: Director, start: 25-04-2023, end: 27-04-2027

Contamine Jérôme

Generaal De Wittelaan L11, box A3, 2800 Mechelen, Belgium

Mandate: Chairman of the board of directors, start: 26-04-2022, end: 28-04-2026

Nodelman Oleg

Generaal De Wittelaan L11, box A3, 2800 Mechelen, Belgium

Mandate: Director, start: 07-10-2024, end: 24-04-2029

Gosebruch Henry

Generaal De Wittelaan L11, box A3, 2800 Mechelen, Belgium

Mandate: Director, start: 12-05-2025, end: 30-04-2030

Bhuva Devang

Generaal De Wittelaan L11, box A3, 2800 Mechelen, Belgium

Mandate: Director, start: 01-11-2025, end: 24-04-2029

Griffiths Jane

Generaal De Wittelaan L11, box A3, 2800 Mechelen, Belgium

Mandate: Director, start: 28-07-2025, end: 30-04-2030

Johnston Neil

Generaal De Wittelaan L11, box A3, 2800 Mechelen, Belgium

Mandate: Director, start: 01-11-2025, end: 25-04-2028

Svoronos Dawn

Generaal De Wittelaan L11, box A3, 2800 Mechelen, Belgium

Mandate: Director, start: 28-07-2025, end: 30-04-2030

Fontoura Paulo

Generaal De Wittelaan L11, box A3, 2800 Mechelen, Belgium

Mandate: Director, start: 09-02-2026, end: 24-04-2029

BDO Bedrijfsrevisoren BV 0431.088.289

Elsinore Building - Da Vincilaan 9, box E6, 1930 Zaventem, Belgium

Membership number: B00023

Mandate: Auditor, start: 25-04-2023, end: 28-04-2026

Represented by:

2/61


N°.		0466.460.429				F-cap 2.1

LIST OF DIRECTORS, BUSINESS MANAGERS AND AUDITORS (continued from previous page)

Lombaerts Ellen

Elsinore Building, Da Vincilaan 9 , box E6 1930 Zaventem Belgium

Bedrijfsrevisor, Membership number : A02372

3/61


N°.		0466.460.429				F-cap 2.2

DECLARATION REGARDING A COMPLIMENTARY REVIEW OR CORRECTION ASSIGNMENT

The managing board declares that not a single audit or correction assignment has been given to a person not authorized to do so by law, pursuant to article 5 of the law of 17 March 2019 concerning the professions of accountant and tax advisor.

The annual accounts ~~were~~ / were not * audited or corrected by a certified accountant or by a company auditor who is not the statutory auditor.

If affirmative, should be mentioned hereafter: surname, first names, profession and address of each certified accountant or company auditor and their membership number at their Institute, as well as the nature of their assignment:

Bookkeeping of the company **,

Preparing the annual accounts **,

Auditing the annual accounts and/or

Correcting the annual accounts.

If the tasks mentioned under A or B are executed by accountants or fiscal accountants, the following information can be mentioned hereafter: surname, first names, profession and address of each accountant or fiscal accountant and their membership number at the Institute of Accountants and Tax advisors, as well as the nature of their assignment.

Surname, first names, profession and address

Membership number

Nature of the

assignment

(A, B, C and/or D)

*	Strike out what does not apply.

**	Optional mention.

4/61


N°.		0466.460.429				F-cap 3.1

ANNUAL ACCOUNTS

BALANCE SHEET AFTER APPROPRIATION


	Notes		Codes		Period		Preceding period
ASSETS
FORMATION EXPENSES		6.1		20

FIXED ASSETS				21/28		130.307.401		423.146.604

Intangible fixed assets		6.2		21		848.834		109.134.253
Tangible fixed assets		6.3		22/27		1.076.376		16.519.206
Land and buildings				22		132.427		354.535
Plant, machinery and equipment				23		774.678		13.329.917
Furniture and vehicles				24		169.271		992.909
Leasing and other similar rights				25
Other tangible fixed assets				26
Assets under construction and advance payments				27		0		1.841.845
Financial fixed assets		6.4 / 6.5.1		28		128.382.191		297.493.145
Affiliated Companies		6.15		280/1		75.765.503		245.176.457
Participating interests				280		40.765.503		198.346.774
Amounts receivable				281		35.000.000		46.829.683
Other companies linked by participating interests		6.15		282/3		1		1
Participating interests				282		1		1
Amounts receivable				283		0
Other financial fixed assets				284/8		52.616.687		52.316.687
Shares				284		50.845.135		50.845.135
Amounts receivable and cash guarantees				285/8		1.771.551		1.471.551

5/61


N°.		0466.460.429				F-cap 3.1


	Notes		Codes	Period		Preceding period
CURRENT ASSETS			29/58		3.211.366.517		3.620.997.441

Amounts receivable after more than one year			29		134.174.533		122.155.102
Trade debtors			290
Other amounts receivable			291		134.174.533		122.155.102
Stocks and contracts in progress			3		22.492.818		51.191.825
Stocks			30/36		22.492.818		51.191.825
Raw materials and consumables			30/31		22.492.818		51.191.825
Work in progress			32				0
Finished goods			33
Goods purchased for resale			34				0
Immovable property intended for sale			35
Advance payments			36
Contracts in progress			37
Amounts receivable within one year			40/41		97.426.920		108.323.176
Trade debtors			40		11.163.550		32.707.724
Other amounts receivable			41		86.263.370		75.615.452
Current investments		6.5.1 / 6.6	50/53		2.865.785.469		3.245.938.470
Own shares			50
Other investments			51/53		2.865.785.469		3.245.938.470
Cash at bank and in hand			54/58		82.268.282		60.140.851
Accruals and deferred income		6.6	490/1		9.218.495		33.248.017

TOTAL ASSETS			20/58		3.341.673.918		4.044.144.044

6/61


N°.		0466.460.429				F-cap 3.2


		Notes		Codes		Period		Preceding period
EQUITY AND LIABILITIES
EQUITY					10/15		3.146.406.781		2.829.483.799

Contributions			6.7.1		10/11		3.017.626.375		3.017.626.375
Capital					10		356.444.939		356.444.939
Issued capital					100		356.444.939		356.444.939
Uncalled capital ⁶					101
Beyond capital					11		2.661.181.436		2.661.181.436
Share premium account					1100/10		2.661.181.436		2.661.181.436
Other					1109/19
Revaluation surpluses					12
Reserves					13		15.846.149
Reserves not available					130/1		15.846.149
Legal reserve					130		15.846.149
Reserves not available statutorily					1311
Purchase of own shares					1312
Financial support					1313
Other					1319
Untaxed reserves					132
Available reserves					133
Accumulated profits (losses)	(+)/(-)				14		112.934.258		-188.142.575
Capital subsidies					15
Advance to shareholders on the distribution of net assets ⁷					19
PROVISIONS AND DEFERRED TAXES					16		60.278.724		17.539.778

Provisions for liabilities and charges					160/5		60.278.724		17.539.778
Pensions and similar obligations					160
Taxes					161
Major repairs and maintenance					162
Environmental obligations					163
Other liabilities and charges			6.8		164/5		60.278.724		17.539.778
Deferred taxes					168

⁶	Amount to be deducted from the issued capital.

⁷	Amount to be deducted from the other components of equity.

7/61


N°.		0466.460.429				F-cap 3.2


	Notes		Codes		Period		Preceding period
AMOUNTS PAYABLE				17/49		134.988.413		1.197.120.467

Amounts payable after more than one year		6.9		17
Financial debts				170/4
Subordinated loans				170
Unsubordinated debentures				171
Leasing and other similar obligations				172
Credit institutions				173
Other loans				174
Trade debts				175
Suppliers				1750
Bills of exchange payable				1751
Advance payments on contracts in progress				176
Other amounts payable				178/9
Amounts payable within one year		6.9		42/48		126.715.797		138.706.338
Current portion of amounts payable after more than one year falling due within one year				42
Financial debts				43
Credit institutions				430/8
Other loans				439
Trade debts				44		95.247.186		92.471.935
Suppliers				440/4		95.247.186		92.471.935
Bills of exchange payable				441
Advance payments on contracts in progress				46
Taxes, remuneration and social security		6.9		45		24.784.628		11.989.497
Taxes				450/3		2.981.568		663.637
Remuneration and social security				454/9		21.803.060		11.325.859
Other amounts payable				47/48		6.683.983		34.244.906
Accruals and deferred income		6.9		492/3		8.272.616		1.058.414.128

TOTAL LIABILITIES				10/49		3.341.673.918		4.044.144.044

⁶	Amount to be deducted from the issued capital.

⁷	Amount to be deducted from the other components of equity.

8/61


N°.		0466.460.429				F-cap 4

PROFIT AND LOSS ACCOUNT


		Notes		Codes		Period		Preceding period
Operating income					70/76A		1.403.066.209		596.121.058
Turnover			6.10		70		1.102.782.320		303.425.198
Stocks of finished goods and work and contracts in progress: increase (decrease)	(+)/(-)				71				-12.598.378
Produced fixed assets					72		294.201.789		265.376.073
Other operating income			6.10		74		6.082.099		39.918.164
Non-recurring operating income			6.12		76A				0
Operating charges					60/66A		1.012.870.795		803.865.509
Goods for resale, raw materials and consumables					60		52.142.080		46.407.800
Purchases					600/8		23.443.074		35.314.994
Stocks: decrease (increase)	(+)/(-)				609		28.699.007		11.092.805
Services and other goods					61		380.338.870		334.587.965
Remuneration, social security and pensions	(+)/(-)		6.10		62		80.453.796		57.872.680
Amortisations of and other amounts written down on formation expenses, intangible and tangible fixed assets					630		312.248.379		283.475.486
Amounts written down on stocks, contracts in progress and trade debtors: additions (write-backs)	(+)/(-)		6.10		631/4		-9.642.778		10.600.456
Provisions for liabilities and charges: appropriations (uses and write-backs)	(+)/(-)		6.10		635/8		42.738.946		3.567.713
Other operating charges			6.10		640/8		43.171.016		27.141.020
Operating charges reported as assets under restructuring costs	(-)				649
Non-recurring operating charges			6.12		66A		111.420.486		40.212.388
Operating profit (loss)	(+)/(-)				9901		390.195.413		-207.744.451

9/61


N°.		0466.460.429				F-cap 4


		Notes		Codes	Period		Preceding period
Financial income				75/76B		194.189.667		257.053.407
Recurring financial income				75		194.026.799		201.081.492
Income from financial fixed assets				750		62.372.391		12.333.065
Income from current assets				751		85.585.244		118.646.628
Other financial income			6.11	752/9		46.069.164		70.101.799
Non-recurring financial income			6.12	76B		162.868		55.971.915
Financial charges			6.11	65/66B		281.067.004		18.646.876
Recurring financial charges				65		123.424.233		18.646.876
Debt charges				650		888.242		1.453.430
Amounts written down on current assets other than stocks, contracts in progress and trade debtors: additions (write-backs)	(+)/(-)			651		2.203.309
Other financial charges				652/9		120.332.682		17.193.446
Non-recurring financial charges			6.12	66B		157.642.771
Profit (Loss) for the period before taxes	(+)/(-)			9903		303.318.076		30.662.079
Transfer from deferred taxes				780
Transfer to deferred taxes				680
Income taxes on the result	(+)/(-)		6.13	67/77		-13.604.906		-17.119.830
Taxes				670/3		30.667		49.571
Adjustment of income taxes and write-back of tax provisions				77		13.635.573		17.169.400
Profit (Loss) of the period	(+)/(-)			9904		316.922.982		47.781.908
Transfer from untaxed reserves				789
Transfer to untaxed reserves				689
Profit (Loss) of the period available for appropriation	(+)/(-)			9905		316.922.982		47.781.908

10/61


N°.		0466.460.429				F-cap 5

APPROPRIATION ACCOUNT


		Codes	Period		Preceding period
Profit (Loss) to be appropriated	(+)/(-)	9906		128.780.407		-188.142.575
Profit (Loss) of the period available for appropriation	(+)/(-)	(9905)		316.922.982		47.781.908
Profit (Loss) of the preceding period brought forward	(+)/(-)	14P		-188.142.575		-235.924.484
Transfers from equity		791/2
from contributions		791
from reserves		792
Appropriations to equity		691/2		15.846.149
to contributions		691
to legal reserve		6920		15.846.149
to other reserves		6921
Profit (loss) to be carried forward	(+)/(-)	(14)		112.934.258		-188.142.575
Shareholders’ contribution in respect of losses		794
Profit to be distributed		694/7
Compensation for contributions		694
Directors or managers		695
Employees		696
Other beneficiaries		697

11/61


N°.		0466.460.429				F-cap 6.2.2

Codes

Period

Preceding period

RESEARCH COSTS MADE IN A PERIOD THAT STARTED BEFORE 1 JANUARY 2016

Acquisition value at the end of the period

8055P

xxxxxxxxxxxxxxx

392.970.251

Movements during the period

Acquisitions, including produced fixed assets

8025

Sales and disposals

8035

Transfers from one heading to another

)/(-)

8045

Acquisition value at the end of the period

8055

392.970.251

Amortisations and amounts written down at the end of the period

8125P

xxxxxxxxxxxxxxx

392.970.251

Movements during the period

Recorded

8075

Written back

8085

Acquisitions from third parties

8095

Cancelled owing to sales and disposals

8105

Transferred from one heading to another

)/(-)

8115

Amortisations and amounts written down at the end of the period

8125

392.970.251

NET BOOK VALUE AT THE END OF THE PERIOD

81312


	Codes		Period
RESEARCH COSTS MADE IN A PERIOD THAT STARTED AFTER 31 DECEMBER 2015
Acquisition value at the end of the period		8056		3.123.533.125
Amortisations and amounts written down at the end of the period		8126		3.123.533.125
NET BOOK VALUE AT THE END OF THE PERIOD		81313		0

12/61


N°.		0466.460.429				F-cap 6.2.3


			Codes		Period		Preceding period
CONCESSIONS, PATENTS LICENSES, KNOW-HOW, BRANDS AND SIMILAR RIGHTS
Acquisition value at the end of the period				8052P		xxxxxxxxxxxxxxx		1.960.941.599
Movements during the period
Acquisitions, including produced fixed assets				8022		294.357.145
Sales and disposals				8032
Transfers from one heading to another	(+	)/(-)		8042
Acquisition value at the end of the period				8052		2.255.298.745
Amortisations and amounts written down at the end of the period				8122P		xxxxxxxxxxxxxxx		1.851.807.347
Movements during the period
Recorded				8072		402.642.564
Written back				8082
Acquisitions from third parties				8092
Cancelled owing to sales and disposals				8102
Transfers from one heading to another	(+	)/(-)		8112
Amortisations and amounts written down at the end of the period				8122		2.254.449.910
NET BOOK VALUE AT THE END OF THE PERIOD				211		848.834

13/61


N°.		0466.460.429				F-cap 6.2.5

Codes

Period

Preceding period

ADVANCE PAYMENTS

Acquisition value at the end of the period

8054P

xxxxxxxxxxxxxxx

Movements during the period

Acquisitions, including produced fixed assets

8024

Sales and disposals

8034

Transfers from one heading to another

)/(-)

8044

Acquisition value at the end of the period

8054

Amortisations and amounts written down at the end of the period

8124P

xxxxxxxxxxxxxxx

Movements during the period

Recorded

8074

Written back

8084

Acquisitions from third parties

8094

Cancelled owing to sales and disposals

8104

Transferred from one heading to another

)/(-)

8114

Amortisations and amounts written down at the end of the period

8124

NET BOOK VALUE AT THE END OF THE PERIOD

213

14/61


N°.		0466.460.429				F-cap 6.3.1

STATEMENT OF TANGIBLE FIXED ASSETS


		Codes		Period		Preceding period
LAND AND BUILDINGS
Acquisition value at the end of the period			8191P		xxxxxxxxxxxxxxx		4.324.048
Movements during the period
Acquisitions, including produced fixed assets			8161		452.598
Sales and disposals			8171		794.176
Transfers from one heading to another	(+)(-)		8181
Acquisition value at the end of the period			8191		3.982.470
Revaluation surpluses at the end of the period			8251P		xxxxxxxxxxxxxxx
Movements during the period
Recorded			8211
Acquisitions from third parties			8221
Cancelled			8231
Transferred from one heading to another	(+)/(-)		8241
Revaluation surpluses at the end of the period			8251
Amortisations and amounts written down at the end of the period			8321P		xxxxxxxxxxxxxxx		3.969.512
Movements during the period
Recorded			8271		148.522
Written back			8281
Acquisitions from third parties			8291
Cancelled owing to sales and disposals			8301		267.991
Transferred from one heading to another	(+)/(-)		8311
Amortisations and amounts written down at the end of the period			8321		3.850.043
NET BOOK VALUE AT THE END OF THE PERIOD			(22)		132.427

15/61


N°.		0466.460.429				F-cap 6.3.2


		Codes		Period		Preceding period
PLANT, MACHINERY AND EQUIPMENT
Acquisition value at the end of the period			8192P		xxxxxxxxxxxxxxx		30.553.873
Movements during the period
Acquisitions, including produced fixed assets			8162		9.390.578
Sales and disposals			8172		26.193.482
Transfers from one heading to another	(+)/(-)		8182
Acquisition value at the end of the period			8192		13.750.969
Revaluation surpluses at the end of the period			8252P		xxxxxxxxxxxxxxx
Movements during the period
Recorded			8212
Acquisitions from third parties			8222
Cancelled			8232
Transferred from one heading to another	(+)/(-)		8242
Revaluation surpluses at the end of the period			8252
Amortisations and amounts written down at the end of the period			8322P		xxxxxxxxxxxxxxx		17.223.955
Movements during the period
Recorded			8272		10.975.514
Written back			8282
Acquisitions from third parties			8292
Cancelled owing to sales and disposals			8302		15.223.179
Transferred from one heading to another	(+)/(-)		8312
Amortisations and amounts written down at the end of the period			8322		12.976.291
NET BOOK VALUE AT THE END OF THE PERIOD			(23)		774.678

16/61


N°.		0466.460.429				F-cap 6.3.3


		Codes		Period		Preceding period
FURNITURE AND VEHICLES
Acquisition value at the end of the period			8193P		xxxxxxxxxxxxxxx		1.567.748
Movements during the period
Acquisitions, including produced fixed assets			8163		1.678.701
Sales and disposals			8173		3.077.179
Transfers from one heading to another	(+)/(-)		8183
Acquisition value at the end of the period			8193		169.271
Revaluation surpluses at the end of the period			8253P		xxxxxxxxxxxxxxx
Movements during the period
Recorded			8213
Acquisitions from third parties			8223
Cancelled			8233
Transfers from one heading to another	(+)/(-)		8243
Revaluation surpluses at the end of the period			8253
Amortisations and amounts written down at the end of the period			8323P		xxxxxxxxxxxxxxx		574.839
Movements during the period
Recorded			8273		226.731
Written back			8283
Acquisitions from third parties			8293
Cancelled owing to sales and disposals			8303		801.571
Transfers from one heading to another	(+)/(-)		8313
Amortisations and amounts written down at the end of the period			8323		0
NET BOOK VALUE AT THE END OF THE PERIOD			(24)		169.271

17/61


N°.		0466.460.429				F-cap 6.3.4

Codes

Period

Preceding period

LEASING AND OTHER SIMILAR RIGHTS

Acquisition value at the end of the period

8194P

xxxxxxxxxxxxxxx

Movements during the period

Acquisitions, including produced fixed assets

8164

Sales and disposals

8174

Transfers from one heading to another

(+)/(-)

8184

Acquisition value at the end of the period

8194

Revaluation surpluses at the end of the period

8254P

xxxxxxxxxxxxxxx

Movements during the period

Recorded

8214

Acquisitions from third parties

8224

Cancelled

8234

Transfers from one heading to another

(+)/(-)

8244

Revaluation surpluses at the end of the period

8254

Amortisations and amounts written down at the end of the period

8324P

xxxxxxxxxxxxxxx

Movements during the period

Recorded

8274

Written back

8284

Acquisitions from third parties

8294

Cancelled owing to sales and disposals

8304

Transferred from one heading to another

(+)/(-)

8314

Amortisations and amounts written down at the end of the period

8324

NET BOOK VALUE AT THE END OF THE PERIOD

(25)

Of which

Land and buildings

250

Plant, machinery and equipment

251

Furniture and vehicles

252

18/61


N°.		0466.460.429				F-cap 6.3.6

Codes

Period

Preceding period

ASSETS UNDER CONSTRUCTION AND ADVANCE PAYMENTS

Acquisition value at the end of the period

8196P

xxxxxxxxxxxxxxx

1.841.845

Movements during the period

Acquisitions, including produced fixed assets

8166

Sales and disposals

8176

1.841.845

Transfers from one heading to another

(+)/(-)

8186

Acquisition value at the end of the period

8196

Revaluation surpluses at the end of the period

8256P

xxxxxxxxxxxxxxx

Movements during the period

Recorded

8216

Acquisitions from third parties

8226

Cancelled

8236

Transferred from one heading to another

(+)/(-)

8246

Revaluation surpluses at the end of the period

8256

Amortisations and amounts written down at the end of the period

8326P

xxxxxxxxxxxxxxx

Movements during the period

Recorded

8276

Written back

8286

Acquisitions from third parties

8296

Cancelled owing to sales and disposals

8306

Transferred from one heading to another

(+)/(-)

8316

Amortisations and amounts written down at the end of the period

8326

NET BOOK VALUE AT THE END OF THE PERIOD

(27)

19/61


N°.		0466.460.429				F-cap 6.4.1

STATEMENT OF FINANCIAL FIXED ASSETS


		Codes		Period		Preceding period
AFFILIATED COMPANIES - PARTICIPATING INTERESTS AND SHARES
Acquisition value at the end of the period			8391P		xxxxxxxxxxxxxxx		208.646.773
Movements during the period
Acquisitions			8361		10.520.601
Sales and disposals			8371		20.759.100
Transfers from one heading to another	(+)/(-)		8381
Acquisition value at the end of the period			8391		198.408.274
Revaluation surpluses at the end of the period			8451P		xxxxxxxxxxxxxxx
Movements during the period
Recorded			8411
Acquisitions from third parties			8421
Cancelled			8431
Transferred from one heading to another	(+)/(-)		8441
Revaluation surpluses at the end of the period			8451
Amounts written down at the end of the period			8521P		xxxxxxxxxxxxxxx		10.299.999
Movements during the period
Recorded			8471		157.642.771
Written back			8481
Acquisitions from third parties			8491
Cancelled owing to sales and disposals			8501		10.300.238
Transferred from one heading to another	(+)/(-)		8511
Amounts written down at the end of the period			8521		157.642.532
Uncalled amounts at the end of the period			8551P		xxxxxxxxxxxxxxx
Movements during the period	(+)/(-)		8541		239
Uncalled amounts at the end of the period			8551		239
NET BOOK VALUE AT THE END OF THE PERIOD			(280)		40.765.503

AFFILIATED COMPANIES - AMOUNTS RECEIVABLE
NET BOOK VALUE AT THE END OF THE PERIOD			281P		xxxxxxxxxxxxxxx		46.829.683

Movements during the period
Appropriations			8581		213.261
Repayments			8591		11.012.437
Amounts written down			8601
Amounts written back			8611
Exchange differences	(+)/(-)		8621
Other movements	(+)/(-)		8631		-1.030.507
NET BOOK VALUE AT THE END OF THE PERIOD			(281)		35.000.000

ACCUMULATED AMOUNTS WRITTEN DOWN ON AMOUNTS RECEIVABLE AT END OF THE PERIOD			8651

20/61


N°.		0466.460.429				F-cap 6.4.2

Codes

Period

Preceding period

COMPANIES LINKED BY PARTICIPATING INTERESTS - PARTICIPATING INTERESTS AND SHARES

Acquisition value at the end of the period

8392P

xxxxxxxxxxxxxxx

Movements during the period

Acquisitions

8362

Sales and disposals

8372

Transfers from one heading to another

(+)/(-)

8382

Acquisition value at the end of the period

8392

Revaluation surpluses at the end of the period

8452P

xxxxxxxxxxxxxxx

Movements during the period

Recorded

8412

Acquisitions from third parties

8422

Cancelled

8432

Transferred from one heading to another

(+)/(-)

8442

Revaluation surpluses at the end of the period

8452

Amounts written down at the end of the period

8522P

xxxxxxxxxxxxxxx

Movements during the period

Recorded

8472

Written back

8482

Acquisitions from third parties

8492

Cancelled owing to sales and disposals

8502

Transferred from one heading to another

(+)/(-)

8512

Amounts written down at the end of the period

8522

Uncalled amounts at the end of the period

8552P

xxxxxxxxxxxxxxx

Movements during the period

(+)/(-)

8542

Uncalled amounts at the end of the period

8552

NET BOOK VALUE AT THE END OF THE PERIOD

(282)

COMPANIES LINKED BY PARTICIPATING INTERESTS - AMOUNTS RECEIVABLE

NET BOOK VALUE AT THE END OF THE PERIOD

283P

xxxxxxxxxxxxxxx

Movements during the period

Appropriations

8582

Repayments

8592

Amounts written down

8602

Amounts written back

8612

Exchange differences

(+)/(-)

8622

Other movements

(+)/(-)

8632

NET BOOK VALUE AT THE END OF THE PERIOD

(283)

ACCUMULATED AMOUNTS WRITTEN DOWN ON AMOUNTS

RECEIVABLE AT END OF THE PERIOD

8652

21/61


N°.		0466.460.429				F-cap 6.4.3

Codes

Period

Preceding period

OTHER COMPANIES—PARTICIPATING INTERESTS AND SHARES

Acquisition value at the end of the period

8393P

xxxxxxxxxxxxxxx

50.845.135

Movements during the period

Acquisitions

8363

Sales and disposals

8373

Transfers from one heading to another

(+)/(-)

8383

Acquisition value at the end of the period

8393

50.845.135

Revaluation surpluses at the end of the period

8453P

xxxxxxxxxxxxxxx

Movements during the period

Recorded

8413

Acquisitions from third parties

8423

Cancelled

8433

Transferred from one heading to another

(+)/(-)

8443

Revaluation surpluses at the end of the period

8453

Amounts written down at the end of the period

8523P

xxxxxxxxxxxxxxx

Movements during the period

Recorded

8473

Written back

8483

Acquisitions from third parties

8493

Cancelled owing to sales and disposals

8503

Transferred from one heading to another

(+)/(-)

8513

Amounts written down at the end of the period

8523

Uncalled amounts at the end of the period

8553P

xxxxxxxxxxxxxxx

Movements during the period

(+)/(-)

8543

Uncalled amounts at the end of the period

8553

NET BOOK VALUE AT THE END OF THE PERIOD

(284)

50.845.135

OTHER COMPANIES—AMOUNTS RECEIVABLE

NET BOOK VALUE AT THE END OF THE PERIOD

285/8P

xxxxxxxxxxxxxxx

1.471.551

Movements during the period

Appropriations

8583

300.000

Repayments

8593

Amounts written down

8603

Amounts written back

8613

Exchange differences

(+)/(-)

8623

Other movements

(+)/(-)

8633

NET BOOK VALUE AT THE END OF THE PERIOD

(285/8)

1.771.551

ACCUMULATED AMOUNTS WRITTEN DOWN ON AMOUNTS

RECEIVABLE AT END OF THE PERIOD

8653

22/61


N°.		0466.460.429				F-cap 6.5.1

PARTICIPATING INTERESTS INFORMATION

PARTICIPATING INTERESTS AND OTHER RIGHTS IN OTHER COMPANIES

The following list mentions the companies in which the company holds a participating interest (recorded in headings 280 and 282 of assets), as well as the companies in which the company holds rights (recorded in headings 284 and 51/53 of assets) for an amount of at least 10% of the capital, the equity or a class of shares of the company.


	Rights held						Data extracted from the most recent annual accounts
NAME, full address of the REGISTERED OFFICE and, for an entity governed by Belgian law, the COMPANY REGISTRATION NUMBER		Directly			Subsidiaries		Annual accounts as per		Currency code		Equity		Net result
	Nature	Number	%		%		Annual accounts as per		Currency code		(+) or (-) (in units)
Galapagos BV								31-12-2025		EUR		7.605.837		700.676
Foreign company
Willem Einthovenstraat 13
2342 BH Oegstgeest
Netherlands
807938397B01
	Registered shares	200		100,00		0,00
Galapagos SASU								31-12-2025		EUR		5.508.149		-123.741
Foreign company
Avenue Gaston Roussel 102
93230 Romainville
France
27440348480
	Registered shares	51.199		100,00		0,00
Galapagos GmbH								31-12-2025		CHF		3.912.111		923.555
Foreign company
Aeschengraben 27
4051 Basel
Switzerland
CHE388581566
	Registered shares	200		100,00		0,00
Galapagos Real Estate Netherlands B.V.								31-12-2025		EUR		27.571.849		-3.156.807
Foreign company
Willem Einthovenstraat 13
2342 BH Oestgeest
Netherlands
860584859B01
	Registered shares	10.000.000		100,00		0,00
Galapagos US Holding Inc								31-12-2025		USD		7.937.563		-433.651
Foreign company
North State Street 800 , box 304
19901 Dover, Delaware
United States
	Registered shares	100		100,00		0,00
Galapagos U.K. ltd								31-12-2025		GBP		649.604		39.036
Foreign company
London End Beaconsfield B
HP9 2JH Bucks
United Kingdom
468175458
	Registered shares	1		100,00		0,00

23/61


N°.		0466.460.429				F-cap 6.5.1

PARTICIPATING INTERESTS INFORMATION

PARTICIPATING INTERESTS AND OTHER RIGHTS IN OTHER COMPANIES

Rights held

Data extracted from the most recent annual
accounts

NAME, full address of the REGISTERED

OFFICE and, for an entity governed by

Belgian law, the COMPANY

REGISTRATION NUMBER

Directly

Subsidiaries

Annual
accounts
as per

Currency
code

Equity

Net
result

Nature

Number

(+) or (-)
(in units)

Galapagos Holding Pte Ltd

31-12-2025

SGD

1.000

-84.833

Foreign company

One Marina Boulevard 28-00

01989 Singapore

Singapore

Registered shares

100

100,00

0,00

Lakefront Therapeutics Inc

31-12-2025

USD

-22.615

Foreign company

North State Street 800

19901 Dover

United States

Registered shares

1.000

100,00

0,00

Galapagos Cell Therapeutics NV

31-12-2025

EUR

6.708

-54.792

Public limited company

Schaliënhoevedreef 20 , box T

2800 Mechelen

Belgium

1020.101.488

Registered shares

61.500

100,00

0,00

24/61


N°.		0466.460.429				F-cap 6.5.2

LIST OF COMPANIES FOR WHICH THE COMPANY HAS UNLIMITED LIABILITY IN THE CAPACITY OF UNLIMITED LIABLE PARTNER OR MEMBER

The annual accounts of each company for which the company has unlimited liability, are being enclosed to and published with these annual accounts, unless the second column contains the reason why this is not the case; this mention is made by referring to the applicable code (A,B, C or D) defined below.

The annual accounts of the mentioned company:

are published by the company by filing them at the National Bank of Belgium;

are actually published by the company in a different member country of the European Union, pursuant to article 16 of directive (EU) 2017/1132;

are being and inserted by complete or proportional consolidation into the the consolidated annual accounts of the company, drawnup,verified and published in accordance with the stipulations of the Belgian Companies and Associations Code concerning the consolidated annual accounts;

concern a limited partnership (société simple/maatschap).


NAME, full address of the REGISTERED OFFICE, LEGAL FORM and, for an entity governed by Belgian law, the COMPANY REGISTRATION NUMBER	Potential code
Galapagos BV		C
Foreign company
Willem Einthovenstraat 13 2342 Oestgeest
Netherlands

Galapagos Real Estate Netherlands B.V.		C
Foreign company
Willem Einthovenstraat 13 2342 Oestgeest
Netherlands

25/61


N°.		0466.460.429				F-cap 6.6

CURRENT INVESTMENTS AND ACCRUALS AND DEFERRED INCOME


	Codes		Period		Preceding period
CURRENT INVESTMENTS—OTHER INVESTMENTS
Shares and investments other than fixed income investments		51
Shares – Book value increased with the uncalled amount		8681
Shares – Uncalled amount		8682
Precious metals and works of art		8683
Fixed-income securities		52
Fixed income securities issued by credit institutions		8684
Term accounts with credit institutions		53		1.433.831.789		1.549.530.651
With a remaining term or notice		8686
up to one month
between one month and one year		8687		1.433.831.789		1.349.530.651
over one year		8688				200.000.000
Other investments not mentioned above		8689		1.431.953.680		1.696.407.819


	Period
ACCRUALS AND DEFERRED INCOME
Allocation of account 490/1 of assets if the amount is significant
Deferred charges		3.317.292
Accrued income: accrued interests		5.901.203

26/61


N°.		0466.460.429				F-cap 6.7.1

STATEMENT OF CAPITAL AND SHAREHOLDERS’ STURCTURE

Codes

Period

Preceding period

STATEMENT OF CAPITAL

Capital

Issued capital at the end of the period

100P

XXXXXXXXXXXXXX

356.444.939

Issued capital at the end of the period

(100

)

356.444.939

Codes

Period

Number of shares

Modifications during the period

Composition of the capital

Share types

Shares without nominal value

356.444.939

65.897.071

Registered shares

8702

XXXXXXXXXXXXXX

5.846

Shares dematerialized

8703

XXXXXXXXXXXXXX

65.891.225

Codes

Uncalled amount

Called up amount, unpaid

Unpaid capital

Uncalled capital

(101

)

XXXXXXXXXXXXXX

Called up capital, unpaid

8712

XXXXXXXXXXXXXX

Shareholders that still need to pay up in full

Codes

Period

Own shares

Held by the company itself

Amount of capital held

8721

Number of shares

8722

Held by a subsidiary

Amount of capital held

8731

Number of shares

8732

Commitments to issuing shares

Owing to the exercise of conversion rights

Amount of outstanding convertible loans

8740

Amount of capital to be subscribed

8741

Corresponding maximum number of shares to be issued

8742

Owing to the exercise of subscription rights

Number of outstanding subscription rights

8745

13.228.810

Amount of capital to be subscribed

8746

71.556.175

Corresponding maximum number of shares to be issued

8747

13.228.810

Authorised capital not issued

8751

27/61


N°.		0466.460.429				F-cap 6.7.1


	Codes		Period
Shares issued, non-representing capital
Distribution
Number of shares		8761
Number of voting rights attached thereto		8762
Allocation by shareholder
Number of shares held by the company itself		8771
Number of shares held by its subsidiaries		8781

			Period
ADDITIONAL NOTES REGARDING CONTRIBUTIONS (INCLUDING CONTRIBUTIONS IN THE FORM OF SERVICES OR KNOW-HOW)

28/61


N°.		0466.460.429				F-cap 6.7.2

SHAREHOLDERS’ STRUCTURE OF THE COMPANY AT YEAR-END CLOSING DATE

As reflected in the notifications received by the company pursuant to article 7:225 of the Belgian Companies and Associations Code, article 14 fourth paragraph of the law of 2 May 2007 on the publication of major holdings and article 5 of the Royal Decree of 21 August 2008 on further rules for certain multilateral trading facilities.


NAME of the persons) who hold rights of the company, together with the ADDRESS (of the registered office, in the case of a legal person) and the COMPANY REGISTRATION NUMBER, in the case of an company governed by Belgian law	Rights held
		Number of voting rights
	Nature	Attached to securities		Not attached to securities		%
Gilead Therapeutics Sir John Rogerson’s Quay 70 D02 Dublin Ireland 3520718FH	Dematerialised shares		16.707.477		0		25,35
Van Herk Investments B.V. Lichtenauerlaan 30 3062 ME Rotterdam Netherlands 853298956B01	Dematerialised shares		4.635.672		0		7,03
EcoR1 Capital LLC Tehema Street 357 94103 San Francisco United States	Dematerialised shares		8.714.522		0		13,22
Tang Capital Management LLC Executive Drive 4747 92121 San Diego United States	Dematerialised shares		5.559.674		0		8,44

29/61


N°.		0466.460.429				F-cap 6.8

PROVISIONS FOR OTHER LIABILITIES AND CHARGES


	Period
ALLOCATION OF ACCOUNT 164/5 OF LIABILITIES IF THE AMOUNT IS SIGNIFICANT
Provision Restricted Stock Units		6.498.795
Tax recovery mechanism		9.466.567
Provision for restructuring cell therapy activities		15.139.596
Provision for restructuring small molecules programs		29.173.766

30/61


N°.		0466.460.429				F-cap 6.9

STATEMENT OF AMOUNTS PAYABLE AND ACCRUALS AND DEFERRED INCOME (LIABILITIES)


	Codes			Period
BREAKDOWN OF AMOUNTS PAYABLE WITH AN ORIGINAL TERM OF MORE THAN ONE YEAR, ACCORDING TO THEIR RESIDUAL MATURITY
Current portion of amounts payable after more than one year falling due within one year
Financial debts		8801
Subordinated loans		8811
Unsubordinated debentures		8821
Leasing and other similar obligations		8831
Credit institutions		8841
Other loans		8851
Trade debts		8861
Suppliers		8871
Bills of exchange payable		8881
Advance payments on contracts in progress		8891
Other amounts payable		8901
Total current portion of amounts payable after more than one year falling due within one year		(42	)
Amounts payable with a remaining term of more than one year, yet less than 5 years
Financial debts		8802
Subordinated loans		8812
Unsubordinated debentures		8822
Leasing and other similar obligations		8832
Credit institutions		8842
Other loans		8852
Trade debts		8862
Suppliers		8872
Bills of exchange payable		8882
Advance payments on contracts in progress		8892
Other amounts payable		8902
Total amounts payable with a remaining term of more than one year, yet less than 5 years		8912
Amounts payable with a remaining term of more than 5 years
Financial debts		8803
Subordinated loans		8813
Unsubordinated debentures		8823
Leasing and other similar obligations		8833
Credit institutions		8843
Other loans		8853
Trade debts		8863
Suppliers		8873
Bills of exchange payable		8883
Advance payments on contracts in progress		8893
Other amounts payable		8903
Amounts payable with a remaining term of more than 5 years		8913

31/61


N°.		0466.460.429				F-cap 6.9


AMOUNTS PAYABLE GUARANTEED (included in accounts 17 and 42/48 of liabilities)	Codes		Period
Amounts payable guaranteed by the Belgian government agencies
Financial debts		8921
Subordinated loans		8931
Unsubordinated debentures		8941
Leasing and other similar obligations		8951
Credit institutions		8961
Other loans		8971
Trade debts		8981
Suppliers		8991
Bills of exchange payable		9001
Advance payments on contracts in progress		9011
Remuneration and social security		9021
Other amounts payable		9051
Total of the amounts payable guaranteed by the Belgian government agencies		9061
Amounts payable guaranteed by real securities given or irrevocably promised by the company on its own assets
Financial debts		8922
Subordinated loans		8932
Unsubordinated debentures		8942
Leasing and other similar obligations		8952
Credit institutions		8962
Other loans		8972
Trade debts		8982
Suppliers		8992
Bills of exchange payable		9002
Advance payments on contracts in progress		9012
Taxes, remuneration and social security		9022
Taxes		9032
Remuneration and social security		9042
Other amounts payable		9052
Total amounts payable guaranteed by real securities given or irrevocably promised by the company on its own assets		9062

	Codes		Period
TAXES, REMUNERATION AND SOCIAL SECURITY
Taxes (headings 450/3 and 178/9 of liabilities)
Outstanding tax debts		9072
Accruing taxes payable		9073		2.981.568
Estimated taxes payable		450
Remuneration and social security (headings 454/9 and 178/9 of liabilities)
Amounts due to the National Social Security Office		9076
Other amounts payable in respect of remuneration and social security		9077		21.803.060

32/61


N°.		0466.460.429				F-cap 6.9


	Period
ACCRUALS AND DEFERRED INCOME
Allocation of heading 492/3 of liabilities if the amount is significant
Discount long-term receivable tax credit		8.272.616

33/61


N°.		0466.460.429				F-cap 6.10

OPERATING RESULTS


	Codes		Period		Preceding period
OPERATING INCOME
Net turnover
Allocation by categories of activity
Research & Development				1.053.007.615		247.205.388
Royalties				19.243.576		15.364.472
Sales of trading goods				30.531.129		40.855.338
Allocation by geographical market
US - United States				1.062.685.731		257.808.758
IT - Italy				38.088.464		16.043.429
SE - Sweden				477.633		4.835.055
NO - Norway				233.184		3.021.981
DK - Denmark				117.309		359.709
CH - Switzerland				1.180.000		0
FR - France						2.103.302
DE - Germany						7.162.418
BE - Belgium						1.126.804
NL - Netherlands						1.103.385
ES - Spain						1.721.170
GB - United Kingdom						3.223.519
IE - Ireland						641.592
AT - Austria						3.461.258
FI - Finland						821.820
Other operating income
Operating subsidies and compensatory amounts received from public authorities		740		56.532		2.034.875
OPERATING CHARGES
Employees for whom the company submitted a DIMONA declaration or who are recorded in the general personnel register
Total number at the closing date		9086		92		278
Average number of employees calculated in full-time equivalents		9087		172,9		291,5
Number of actual hours worked		9088		266.901		491.991
Personnel costs
Remuneration and direct social benefits		620		61.687.696		40.665.852
Employers’ contribution for social security		621		14.851.868		11.108.390
Employers’ premiums for extra statutory insurance		622		1.331.578		2.241.211
Other personnel costs		623		2.582.654		3.857.227
Retirement and survivors’ pensions		624

34/61


N°.		0466.460.429				F-cap 6.10


			Codes		Period		Preceding period
Provisions for pensions and similar obligations
Appropriations (uses and write-backs)	(+	)/(-)		635
Depreciations
On stock and contracts in progress
Recorded				9110				957.678
Written back				9111
On trade debtors
Recorded				9112		717.711		9.642.778
Written back				9113		10.360.489
Provisions for liabilities and charges
Appropriations				9115		42.738.946		5.776.280
Uses and write-backs				9116				2.208.567
Other operating charges
Taxes related to operation				640		3.111.434		3.422.772
Other				641/8		40.059.583		23.718.249
Hired temporary staff and personnel placed at the company’s disposal
Total number at the closing date				9096
Average number calculated in full-time equivalents				9097		0,2		0,5
Number of actual hours worked				9098		382		1.176
Costs to the company				617		8.471		26.425

35/61


N°.		0466.460.429				F-cap 6.11

FINANCIAL RESULTS


	Codes		Period		Preceding period
RECURRING FINANCIAL INCOME
Other financial income
Subsidies paid by public authorities, added to the profit and loss account
Capital subsidies		9125
Interest subsidies		9126
Allocation of other financial income
Exchange differences realized		754		14.129.928
Other
Other financial gain				23.233		34.324
Unrealized exchange gains				5.990.502		61.227.843
Realized gain on money market funds				25.925.501		8.839.633

RECURRING FINANCIAL CHARGES
Depreciation of loan issue expenses		6501
Capitalised interests		6502		0		1.453.430
Depreciations on current assets
Recorded		6510		2.203.309
Written back		6511
Other financial charges
Amount of the discount borne by the company, as a result of negotiating amounts receivable		653
Provisions of a financial nature
Appropriations		6560
Uses and write-backs		6561
Allocation of other financial costs
Exchange differences realized		654				16.407.529
Results from the conversion of foreign currencies		655
Other
Unrealized exchange losses				119.816.900		111.879
Bank charges				513.827		665.700
Payment differences				1.939		739
Other financial charges				16		7.600

36/61


N°.		0466.460.429				F-cap 6.12

INCOME AND CHARGES OF EXCEPTIONAL SIZE OR FREQUENCY


		Codes			Period		Preceding period
NON-RECURRING INCOME			76			162.868		55.971.915
Non-recurring operating income			(76A	)				0
Write-back of depreciation and of amounts written off intangible and tangible fixed assets			760
Write-back of provisions for extraordinary operating liabilities and charges			7620
Capital profits on disposal of intangible and tangible fixed assets			7630					0
Other non-recurring operating income			764/8
Non-recurring financial income			(76B	)		162.868		55.971.915
Write-back of amounts written down financial fixed assets			761
Write-back of provisions for extraordinary financial liabilities and charges			7621
Capital profits on disposal of financial fixed assets			7631			162.868		55.971.915
Other non-recurring financial income			769
NON-RECURRING CHARGES			66			269.063.257		40.212.388
Non-recurring operating charges			(66A	)		111.420.486		40.212.388
Non-recurring depreciation of and amounts written off formation expenses, intangible and tangible fixed assets			660			101.758.468
Provisions for extraordinary operating liabilities and charges:
appropriations (uses)	(+)/(-)		6620
Capital losses on disposal of intangible and tangible fixed assets			6630			9.662.018		212.388
Other non-recurring operating charges			664/7					40.000.000
Non-recurring operating charges carried to assets as restructuring costs	(-)		6690
Non-recurring financial charges			(66B	)		157.642.771
Amounts written off financial fixed assets			661			157.642.771
Provisions for extraordinary financial liabilities and charges - appropriations (uses)	(+)/(-)		6621
Capital losses on disposal of financial fixed assets			6631
Other non-recurring financial charges			668
Non-recurring financial charges carried to assets as restructuring costs	(-)		6691

37/61


N°.		0466.460.429				F-cap 6.13

TAXES


	Codes		Period
INCOME TAXES
Income taxes on the result of the period		9134		30.667
Income taxes paid and withholding taxes due or paid		9135		305.640
Excess of income tax prepayments and withholding taxes paid recorded under assets		9136		305.640
Estimated additional taxes		9137		30.667
Income taxes on the result of prior periods		9138
Additional income taxes due or paid		9139
Additional income taxes estimated or provided for		9140
Major reasons for the differences between pre-tax profit, as it results from the annual accounts, and estimated taxable profit
Non-deductible expenses				4.512.558
Tax credit				-14.770.668
Excess depreciations				-158.811.049
Exemption regional contributions				-56.532
Taxable depreciation				147.836.887
Taxable provisions				154.881.545
FTI deduction				62.372.391
Innovation income deduction				387.860.774


			Period
Influence of non-recurring results on income taxes on the result of the period


	Codes		Period
Sources of deferred taxes
Deferred taxes representing assets		9141		1.828.043.735
Accumulated tax losses deductible from future taxable profits		9142		823.087.824
Other deferred taxes representing assets
Investment deduction				966.348
Deduction for innovation income				659.995.791
Excess depreciations				286.840.743
FTI				31.022.113
Deferred taxes representing liabilities		9144
Allocation of deferred taxes representing liabilities

38/61


N°.		0466.460.429				F-cap 6.13

TAXES


	Codes		Period		Preceding period
VALUE-ADDED TAXES AND TAXES BORNE BY THIRD PARTIES
Value-added taxes charged
To the company (deductible)		9145		16.354.894		21.584.146
By the company		9146		3.956.078		1.957.981
Amounts withheld on behalf of third party by way of
Payroll withholding taxes		9147		21.374.476		19.940.397
Withholding taxes on investment income		9148

39/61


N°.		0466.460.429				F-cap 6.14

RIGHTS AND COMMITMENTS NOT REFLECTED IN THE BALANCE SHEET


	Codes		Period
PERSONAL GUARANTEES PROVIDED OR IRREVOCABLY PROMISED BY THE COMPANY AS
SECURITY FOR DEBTS AND COMMITMENTS OF THIRD PARTIES		9149		1.771.551

Of which
Bills of exchange in circulation endorsed by the company		9150
Bills of exchange in circulation drawn or guaranteed by the company		9151
Maximum amount for which other debts or commitments of third parties are guaranteed by the company		9153		1.771.551
REAL GUARANTEES
Real guarantees provided or irrevocably promised by the company on its own assets as security of debts and commitments of the company
Mortgages
Book value of the immovable properties mortgaged		91611
Amount of registration		91621
For irrevocable mortgage mandates, the amount for which the agent can take registration		91631
Pledging of goodwill
Maximum amount up to which the debt is secured and which is the subject of registration		91711
For irrevocable mandates to pledge goodwill, the amount for which the agent can take the inscription		91721
Pledging of other assets or irrevocable mandates to pledge other assets
Book value of the immovable properties mortgaged		91811
Maximum amount up to which the debt is secured		91821
Guarantees provided or irrevocably promised on future assets
Amount of assets in question		91911
Maximum amount up to which the debt is secured		91921
Vendor’s privilege
Book value of sold goods		92011
Amount of the unpaid price		92021

40/61


N°.		0466.460.429				F-cap 6.14


	Codes		Period
Real guarantees provided or irrevocably promised by the company on its own assets as security of debts and commitments of third parties
Mortgages
Book value of the immovable properties mortgaged		91612
Amount of registration		91622
For irrevocable mortgage mandates, the amount for which the agent can take registration		91632
Pledging of goodwill
Maximum amount up to which the debt is secured and which is the subject of registration		91712
For irrevocable mandates to pledge goodwill, the amount for which the agent can take the inscription		91722
Pledging of other assets or irrevocable mandates to pledge other assets
Book value of the immovable properties mortgaged		91812
Maximum amount up to which the debt is secured		91822
Guarantees provided or irrevocably promised on future assets
Amount of assets in question		91912
Maximum amount up to which the debt is secured		91922
Vendor’s privilege
Book value of sold goods		92012
Amount of the unpaid price		92022

	Codes		Period
GOODS AND VALUES, NOT REFLECTED IN THE BALANCE SHEET, HELD BY THIRD PARTIES IN THEIR OWN NAME BUT FOR THE BENEFIT AND AT THE RISK OF THE COMPANY
SUBSTANTIAL COMMITMENTS TO ACQUIRE FIXED ASSETS
SUBSTANTIAL COMMITMENTS TO DISPOSE OF FIXED ASSETS
FORWARD TRANSACTIONS
Goods purchased (to be received)		9213
Goods sold (to be delivered)		9214
Currencies purchased (to be received)		9215
Currencies sold (to be delivered)		9216

			Period
COMMITMENTS RELATING TO TECHNICAL GUARANTEES IN RESPECT OF SALES OR SERVICES

			Period
AMOUNT, NATURE AND FORM CONCERNING LITIGATION AND OTHER IMPORTANT COMMITMENTS

41/61


N°.		0466.460.429				F-cap

SETTLEMENT REGARDING THE COMPLEMENTARY RETIREMENT OR SURVIVORS’ PENSION FOR PERSONNEL AND BOARD MEMBERS

Brief description

Galapagos NV has a group insurance and guaranteed income insurance in favor of their personnel and directors. Galapagos NV carries all costs related to these insurances. The amount of the premium contribution was 1.576K EUR in 2025.

Measures taken to cover the related charges


	Code		Period
PENSIONS FUNDED BY THE COMPANY ITSELF
Estimated amount of the commitments resulting from past services		9220
Methods of estimation
Galapagos NV has a group insurance and guaranteed income insurance in favor of their personnel and directors. Galapagos NV carries all costs related to these insurances. The amount of the premium contribution was 1.576K EUR in 2025.

			Period
NATURE AND FINANCIAL IMPACT OF SIGNIFICANT EVENTS AFTER THE CLOSING DATE not reflected in the balance sheet or income statement
On January 5, 2026, it was announced that the cell therapy activities would be discontinued. A one-off restructuring impact of EUR 125–175 million is expected here.				0

			Period
COMMITMENTS TO PURCHASE OR SALE AVAILABLE TO THE COMPANY AS ISSUER OF OPTIONS FOR SALE OR PURCHASE

			Period
NATURE, COMMERCIAL OBJECTIVE AND FINANCIAL CONSEQUENCES OF TRANSACTIONS NOT REFLECTED IN THE BALANCE SHEET
If the risks and benefits resulting from such transactions are of any meaning and if publishing such risks and benefits is necessary to appreciate the financial situation of the company

			Period
OTHER RIGHTS AND COMMITMENTS NOT REFLECTED IN THE BALANCE SHEET (including those that cannot be calculated)
As of 1 February 2024, we are entitled to earn-outs on the net sales of Jyseleca^® by Alfasiga in Europe, which are estimated at 54 million euros.				54.000.000

42/61


N°.		0466.460.429				F-cap

RELATIONSHIPS WITH AFFILIATED COMPANIES, ASSOCIATED COMPANIES AND OTHER COMPANIES LINKED BY PARTICIPATING INTERESTS


	Codes			Period		Preceding period
AFFILIATED COMPANIES
Financial fixed assets		(280/1	)		75.765.503		245.176.457
Participating interests		(280	)		40.765.503		198.346.774
Subordinated amounts receivable		9271			35.000.000		46.829.683
Other amounts receivable		9281
Amounts receivable		9291			62.414.060		53.455.169
Over one year		9301
Within one year		9311			62.414.060		53.455.169
Current investments		9321
Shares		9331
Amounts receivable		9341
Amounts payable		9351			76.762.303		69.429.394
Over one year		9361
Within one year		9371			76.762.303		69.429.394
Personal and real guarantees
Provided or irrevocably promised by the company as security for debts or commitments of affiliated companies		9381			28.243.684		2.974.155
Provided or irrevocably promised by affiliated companies as security for debts or commitments of the company		9391
Other significant financial commitments		9401
Financial results
Income from financial fixed assets		9421			62.372.391		12.333.065
Income from current assets		9431			3.866.929		5.449.829
Other financial income		9441
Debt charges		9461			484.368		1.130.204
Other financial charges		9471
Disposal of fixed assets
Capital profits realised		9481
Capital losses realised		9491

43/61


N°.		0466.460.429				F-cap

RELATIONSHIPS WITH AFFILIATED COMPANIES, ASSOCIATED COMPANIES AND OTHER COMPANIES LINKED BY PARTICIPATING INTERESTS


	Codes		Period		Preceding period
ASSOCIATED COMPANIES
Financial fixed assets		9253
Participating interests		9263
Subordinated amounts receivable		9273
Other amounts receivable		9283
Amounts receivable		9293
Over one year		9303
Within one year		9313
Amounts payable		9353
Over one year		9363
Within one year		9373
Personal and real guarantees
Provided or irrevocably promised by the company as security for debts or commitments of affiliated companies		9383
Provided or irrevocably promised by affiliated companies as security for debts or commitments of the company		9393
Other significant financial commitments		9403
COMPANIES LINKED BY PARTICIPATING INTERESTS
Financial fixed assets		9252		1		1
Participating interests		9262		1		1
Subordinated amounts receivable		9272
Other amounts receivable		9282
Amounts receivable		9292
Over one year		9302
Within one year		9312
Amounts payable		9352
Over one year		9362
Within one year		9372

44/61


N°.		0466.460.429				F-cap

RELATIONSHIPS WITH AFFILIATED COMPANIES, ASSOCIATED COMPANIES AND OTHER COMPANIES LINKED BY PARTICIPATING INTERESTS


		Period
TRANSACTIONS WITH AFFILIATED PARTIES BEYOND NORMAL MARKET CONDITIONS
Mention of these transactions if they are significant, including the amount of the transactions, the nature of the link, and all information about the transactions that should be necessary to get a better understanding of the financial situation of the company
Due to the absence of legal criteria that allow transactions with affiliated parties beyond normal market conditions to be enumerated, no transactions were included in F-cap 6.15.

45/61


N°.		0466.460.429				F-cap

FINANCIAL RELATIONSHIPS WITH


	Codes		Period
DIRECTORS AND MANAGERS, INDIVIDUALS OR LEGAL PERSONS WHO CONTROL THE COMPANY DIRECTLY OR INDIRECTLY WITHOUT BEING ASSOCIATED THEREWITH, OR OTHER COMPANIES CONTROLLED DIRECTLY OR INDIRECTLY BY THESE PERSONS
Amounts receivable from these persons		9500
Principal conditions regarding amounts receivable, rate of interest, duration, any amounts repaid, cancelled or written off
Guarantees provided in their favour		9501
Other significant commitments undertaken in their favour		9502
Amount of direct and indirect remunerations and pensions, reflected in the income statement, as long as this disclosure does not concern exclusively or mainly, the situation of a single identifiable person
To directors and managers		9503		4.295.365
To former directors and former managers		9504

	Codes		Period
THE AUDITOR(S) AND THE PERSONS WHOM HE (THEY) IS (ARE) COLLABORATING WITH
Auditors’ fees		9505		1.099.821
Fees for exceptional services or special assignments executed within the company by the auditor
Other audit assignments		95061		250.929
Tax consultancy assignments		95062
Other assignments beyondthe audit		95063		34.634
Fees for exceptional services or special assignments executed within the company by people the auditor(s) is (are collaborating with
Other audit assignments		95081
Tax consultancy assignments		95082		15.055
Other assignments beyond the audit		95083

Mentions related to article 3:64, § 2 and § 4 of the Belgian Companies and Associations Code

46/61


N°.		0466.460.429				F-cap

DECLARATION WITH REGARD TO THE CONSOLIDATED ANNUAL ACCOUNTS

INFORMATION TO DISCLOSE BY EACH COMPANY GOVERNED BY THE BELGIAN COMPANIES AND ASSOCIATIONS CODE ON THE CONSOLIDATED ANNUAL ACCOUNTS

The company has prepared and published consolidated annual accounts and a consolidated annual report*

Name, full address of the registered office and, if it concerns companies under Belgian law, the company registration number of the parent company(ies) and the indication if this (these) parent company(ies) prepares (prepare) and publishes (publish) consolidated annual accounts, in which the annual accounts are included by means of consolidation**:

If the parent company(ies) is (are) (a) company(ies) governed by foreign law, the location where the abovementioned annual accounts are available**:

*	Strike out what does not apply.

**	Where the annual accounts of the company are consolidated at different levels, the information should be given, on the one hand at the highest and on the other at the lowest level of companies of which the company is a subsidiary and for which consolidated accounts are prepared and published.

47/61


N°.		0466.460.429				F-cap

VALUATION RULES

The valuation rules are established in accordance with the provisions of the Royal Decree of 29 April 2019 implementing the Code of Companies and Associations and are valid for the valuation of all assets, receivables, debts, and commitments of the company.

Any changes will be submitted to the Board of Directors for approval in advance.

The current rules have been drawn up and the valuation rules are implemented with a view to the continuation of the company.

Summary of the Valuation Rules:

1. Fixed assets

a) Intangible fixed assets

The company invests in research and development projects. From financial year 2010 onwards, research and development costs are only capitalized to the extent that their cost does not exceed a prudent estimate of their use value or their future return for the enterprise and are depreciated over a period of 3 years up to and including financial year 2015. From financial year 2016 onwards, research and development costs that do not qualify as part of a development phase are capitalized and fully depreciated in the same financial year (in accordance with CBN opinions 2016/16 and 2016/27).

Research and development in progress acquired through licensing agreements, business combinations, cooperation agreements, or separate acquisitions are recognized as intangible assets if they are separately identifiable, are audited by us, and can generate economic benefit. Since the probability criterion is always considered to be met for separately acquired research and development assets, upfront and success payments to third parties for products or drug candidates for which approval has not yet been received are recognized as intangible assets. We do not consider these intangible assets to be available for use until the underlying asset has been approved and commercially launched. From the moment of approval for commercialization of the underlying asset, depreciation is recorded and the asset will be depreciated over its useful life.

Licenses, patents, and know-how are depreciated on a linear basis over the useful life (usually between 5 and 20 years).

Other intangible fixed assets, including acquired intellectual property, are recorded at acquisition cost. These assets are depreciated linearly over the estimated useful life once they are ready for their intended use. They are recognized as assets to the extent that their net book value does not exceed a prudent estimate of their value in use or their future return for the enterprise.

At each balance sheet date, we review the carrying amount of our intangible assets to determine whether there is an indication that these assets have suffered impairment. If such an indication exists, the realizable value of the asset is estimated to determine the amount of the impairment (if any).

b) Tangible fixed assets

Tangible fixed assets are recorded at cost. Depreciation is calculated on a linear basis, taking into account the economic life of the assets.

•

Laboratory equipment: 5-10 years

•

IT hardware and software: 3-5 years

•

Furniture and rolling stock: 5-10 years

At each balance sheet date, we examine the carrying amount of our tangible fixed assets to determine whether there is an indication that these assets have suffered impairment. If such an indication exists, the realizable value of the asset is estimated to determine the extent of the impairment (if any).

2. Receivables

Receivables are recorded at nominal value. Receivables in foreign currency are converted at the exchange rate valid on the balance sheet date. Exchange rate differences are recognized in the income statement.

If collection becomes doubtful, a provision is made for impairment.

3. Inventories

Raw materials, auxiliary goods, and merchandise are valued at acquisition cost.

Goods in process and finished products are valued at cost. In addition to direct production and material costs, cost includes a proportionate share of the depreciation and impairment of the assets used in the production process.

Inventories are valued according to the FIFO method. If the acquisition value or cost price is higher than the realizable value, the valuation at the lower realizable value is applied. The realizable value is equal to the estimated normal selling price, less the estimated finishing costs and estimated costs required to realize the sale.

4. Cash investments and liquid assets

Securities held with financial institutions are valued at nominal value. Securities are valued at acquisition cost.

Incidental costs are immediately charged to the result. Impairment losses are recognized if the realizable value at the balance sheet date is lower than the amount previously recorded.

Securities in foreign currency are converted at the exchange rate valid on the balance sheet date. Exchange rate differences are recognized in the income statement.

5. Provisions for other risks and costs.

This year, provisions for restricted stock units, the tax recovery mechanism for subscription rights, and contract terminations were included in this, following the CBN advice of 2018/16, and this reasoning was maintained for the deferred management bonus.

Provisions are recognized in the balance sheet when we have a current obligation as a result of a past event; when it is probable that an outflow of resources with economic benefits will be required to settle the obligations and a reliable estimate can be made of the amount of the obligations. The amount recognized as a provision is the best estimate of the expenditure required to settle the current obligation at the balance sheet date.

48/61


N°.		0466.460.429				F-cap

VALUATION RULES

6. Revenue

Revenue to date consists primarily of success payments, license fees, and advance payments derived from collaboration agreements. The company also generates revenue from various research and development incentives and grants.

Collaboration agreements with the company’s commercial partners for activities related to research and development generally contain non-refundable advance payments received; success payments, the receipt of which is dependent on the achievement of certain clinical, regulatory, or commercial milestones; license fees and royalties on sales.

In the event of revenue recognition spread over time, the unrecognized portion is recorded as carried-forward revenue.

The revenue recognition policy can be summarized as follows:

a) Prepayments received

Non-refundable prepayments received in connection with research and development cooperation agreements are spread and recognized over the relevant and desired period of the company’s performance obligation.

The payments and the company’s involvement are contractually defined per phase. At the outset, Management makes an estimate of the duration of the company’s involvement, as well as the costs related to the project.

Prepayments are recognized over the expected period of involvement, either on a linear basis or based on the costs incurred within the framework of the project if these costs can be reliably estimated. Periodically, the company assesses the estimated time and costs for the project and adjusts the period over which the revenue is spread.

b) Successors

A successor is only included in the transaction price when it is highly probable that a substantial reversal of the cumulative recognized revenue will not occur.

Successors that are not irrevocable, substantial, or proportionate are recognized as deferred revenue. Revenue from these activities can vary significantly from period to period due to the timing of the successor.

c) Licenses

Revenue derived from time-limited licenses is spread over the period to which the license relates, reflecting the obligation of the licensee over that term to update the content and to ensure continuous updating.

Revenue from perpetual licenses is recognized immediately upon sale to the extent that there are no further obligations.

d) Royalty Agreements

Royalty revenues are recognized at the moment the company can estimate the amount with reasonable certainty and there is reasonable certainty regarding collectability. Consequently, the company generally recognizes the royalties in the period that the licensee has reported the royalties to the company by means of royalty reports; this means that the revenues from the royalties are normally only recognized retrospectively, after the period in which sales by the licensee have taken place. Under this accounting rule, the revenues arising from royalties in the company’s reporting are not based on an estimate by the company but are typically reported in the same period as the receipt of payment from the licensee.

e) Subsidies and R&D support measures

Because the company participates extensively in research and development activities, the company also benefits from several subsidies and R&D support measures from certain government agencies. These subsidies and R&D support measures are generally used to partially reimburse the approved research and development costs. They are therefore credited to the result, under other income (excluding tax credit for research and development costs), when the relevant expenses have been incurred and there is reasonable certainty regarding the subsidies and R&D support measures (to be) received.

f) Sale of trading goods:

After the completion of the sale of the Jyseleca^® activities, we began to recognize the sale of Jyseleca^® stocks to Alfasigma as revenue from deliveries, as part of the continuing activities. These revenues from deliveries are recognized at the moment when control of the products in stock is transferred to Alfasigma.

(g) Proceeds recognition from collaboration with Gilead to develop filgotinib

•

Identification of the contract

Despite the recent additional amendment to the cooperation agreement with Gilead for the development of filgotinib, management judged that all activities are still beneficial to the development of filgotinib, for which Gilead still retains rights outside Europe. All contract amendments were analyzed as we are of the opinion that Gilead must still be considered a customer. This is also supported by the fact that we concluded that only one result obligation remains related to filgotinib.

•

Identification of the obligation of result

The recent changes to the cooperation agreement with Gilead did not give rise to new obligations of result. There was only an adjustment in the scope and price of the existing filgotinib obligation of result, which was only partially fulfilled at the time of the change.

•

Allocation of the total transaction price

We judged that the contract amendment affects only the scope of the filgotinib result obligation and that the change in both the fixed and variable remuneration reflects the adjusted stand-alone sales price of the remaining activities of this result obligation. Had we judged that the higher remuneration was not or only partially related to the filgotinib result obligation, then the remuneration might have been allocated to other result obligations in the contract, leading to a change in the timing of revenue recognition.

The denominator used in the calculation of the percentage of completion reflects our best estimate of our total costs required to meet the filgotinib result obligation.

h) recognition of revenues from OLCA Agreement

•

In 2025, the following changes and other events took place:

•

On 7 January 2025, Gilead waived its rights under the OLCA regarding all our small molecule R&D activities and programs;

•

On 23 July 2025, we and Gilead signed an agreement regarding the waiver and royalties for the cell therapy activities, which constitutes an amendment to the OLCA;

49/61


Nr.		0466.460.429				F-cap 6.19

VALUATION RULES

•

On 21 October 2025, we announced our intention to phase out our cell therapy activities, which was confirmed on 5 January 2026 following the conclusion of the consultation process with the Works Council. - Following the changes to the OLCA in 2025 and other events as described above, as of December 31, 2025, we will no longer have an internal program on which Gilead could exercise the OLCA access and option right outside of the programs to which the phase-out applies, and there are no ongoing R&D activities that could lead to a new internal program to which the OLCA access and option right could become applicable during the remaining term of the OLCA.

•

Although the OLCA access and option right could also apply to programs that we acquire in the future, such an acquisition transaction (whether by license, merger, acquisition, reorganization, consolidation or combination, or any other transaction) is a sovereign decision to be taken by the Management Board, which comprises independent directors who constitute a minority. Given that the prepayment received by us under the OLCA is non-refundable and the OLCA does not obligate us to make acquisitions, Gilead’s OLCA access and option right does not constitute an enforceable obligation of result from an accounting perspective with respect to acquired programs, as it does not exist independently of our future sovereign actions and decisions.

•

Based on the above considerations and although the amended OLCA remains contractually in effect as of December 31, 2025, our management is of the opinion that, following the OLCA amendments of 2025 and other events, there no longer exists an enforceable obligation of result under the amended OLCA that would justify a “contractual obligation” to maintain it as of December 31, 2025, including with respect to the OLCA access and option right for both internal programs and programs that might be acquired in the future during the remaining term of the OLCA. - Consequently, the carry-forward revenue of 1.051 million that we reported as at 31 December 2024 in relation to the OLCA was no longer recognized and was acknowledged as revenue in 2025.

7. Continuity

To date, we have realized a strong profit, which is reflected in the consolidated balance sheet with € 210.6 million in accumulated profits as at 31 December 2025. We realized a consolidated net profit of € 320.9 million for the year ended at 31 December 2025. Financial investments and cash and cash equivalents amounted to € 2,998.0 million as at 31 December 2025.

8. Financial fixed assets

Financial fixed assets are valued at cost. Impairment losses are recognized in the event of a permanent decrease in value.

50/61

LOGO

N°. 0466.460.429 F-cap 8 AUDITORS’ REPORT

LOGO


N°.		0466.460.429				F-cap 10

SOCIAL BALANCE SHEET

Numbers of the joint industrial committees competent for the company: 207

STATEMENT OF THE PERSONS EMPLOYED

EMPLOYEES FOR WHOM THE COMPANY SUBMITTED A DIMONA DECLARATION OR WHO ARE RECORDED IN THE GENERAL PERSONNEL REGISTER


During the period	Codes		Total		1. Men		2. Women
Average number of employees
Full-time		1001		157,3		69,8		87,5
Part-time		1002		19,0		2,0		17,0
Total in full-time equivalents (FTE)		1003		172,9		71,5		101,4
Number of actual hours worked
Full-time		1011		242.744		113.176		129.568
Part-time		1012		24.157		2.794		21.363
Total		1013		266.901		115.970		150.931
Personnel costs
Full-time		1021		73.424.700		37.086.228		36.338.472
Part-time		1022		7.029.096		543.373		6.485.724
Total		1023		80.453.796		37.629.600		42.824.196
Benefits in addition to wages		1033		451.285		193.155		258.130


During the preceding period	Codes		P. Total		1P. Men		2P. Women
Average number of employees in FTE		1003		291,5		123,5		168,0
Number of actual hours worked		1013		491.991		212.188		279.803
Personnel costs		1023		57.872.680		28.734.999		29.137.681
Benefits in addition to wages		1033		451.285		193.155		258.130

58/61


N°.		0466.460.429				F-cap 10

EMPLOYEES FOR WHOM THE COMPANY SUBMITTED A DIMONA DECLARATION OR WHO ARE RECORDED IN THE GENERAL PERSONNEL REGISTER (continuation)


At the closing date of the period	Codes		1. Full-time		2. Part-time		3. Total in full-time equivalents
Number of employees		105		78		14		89,2
By nature of the employment contract
Contract for an indefinite period		110		78		14		89,2
Contract for a definite period		111
Contract for the execution of a specifically assigned work		112
Replacement contract		113
According to gender and study level
Men		120		36		2		37,8
primary education		1200		3				3,0
secondary education		1201		2				2,0
higher non-university education		1202		6		1		6,9
university education		1203		25		1		25,9
Women		121		42		12		51,4
primary education		1210		1				1,0
secondary education		1211		2				2,0
higher non-university education		1212		11		5		15,1
university education		1213		28		7		33,3
By professional category
Management staff		130
Salaried employees		134		78		14		89,2
Hourly employees		132
Other		133

HIRED TEMPORARY STAFF AND PERSONNEL PLACED AT THE DISPOSAL OF THE COMPANY


During the period	Codes		1. Hired temporary staff		2. Hired temporary staff and personnel placed at the company’s disposal
Average number of persons employed		150		0,2
Number of actual hours worked		151		382
Costs to the company		152		8.471

59/61


N°.		0466.460.429				F-cap 10

LIST OF PERSONNEL MOVEMENTS DURING THE PERIOD


ENTRIES	Codes		1. Full-time		2. Part-time		3. Total in full-time equivalents
Number of employees for whom the company submitted a DIMONA declaration or who have been recorded in the general personnel register during the period		205		90		1		90,9
By nature of the employment contract
Contract for an indefinite period		210		90		1		90,9
Contract for a definite period		211
Contract for the execution of a specifically assigned work		212
Replacement contract		213


DEPARTURES	Codes		1. Full-time		2. Part-time		3. Total in full-time equivalents
Number of employees whose contract-termination date has been included in the DIMONA declaration or in the general personnel register during the period		305		257		20		273,6
By nature of the employment contract
Contract for an indefinite period		310		257		20		273,6
Contract for a definite period		311
Contract for the execution of a specifically assigned work		312
Replacement contract		313
By reason of termination of contract
Retirement		340
Unemployment with extra allowance from enterprise		341
Dismissal		342		246		19		261,8
Other reason		343		11		1		11,8
Of which: the number of persons who continue to render services to the company at least half-time on a self-employment basis		350

60/61


N°.		0466.460.429				F-cap 10

INFORMATION ON TRAINING PROVIDED TO EMPLOYEES DURING THE PERIOD


Total of initiatives of formal professional training at the expense of the employer	Codes		Men		Codes		Women
Number of employees involved		5801		3		5811		4
Number of actual training hours		5802		220		5812		313
Net costs for the company		5803		24.966		5813		36.523
of which gross costs directly linked to training		58031		16.101		58131		26.160
of which contributions paid and payments to collective funds		58032		8.865		58132		10.364
of which grants and other financial advantages received (to deduct)		58033				58133
Total of initiatives of less formal or informal professional training at the expense of the employer
Number of employees involved		5821				5831
Number of actual training hours		5822				5832
Net costs for the company		5823				5833
Total of initial initiatives of professional training at the expense of the employer
Number of employees involved		5841				5851
Number of actual training hours		5842				5852
Net costs for the company		5843				5853

61/61